down arrow

Uni-Bio Science Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG9198H1406
HKD
0.10
0 (3.09%)

Apr 02

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
China Isotope & Radiation Corp.
PW Medtech Group Ltd.
Uni-Bio Science Group Ltd.
Essex Bio-Technology Ltd.
Beijing Chunlizhengda Medical Instruments Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd.
Sisram Medical Ltd.
Shanghai Heartcare Medical Technology Corp. Ltd.
Shanghai Conant Optical Co., Ltd.
Broncus Holding Corp.
Venus Medtech (Hangzhou), Inc.

Why is Uni-Bio Science Group Ltd. ?

1
High Management Efficiency with a high ROE of 14.78%
2
Strong Long Term Fundamental Strength with a 26.84% CAGR growth in Net Sales
3
Healthy long term growth as Net Sales has grown by an annual rate of 26.84%
4
The company declared negative results in Dec'24 after positive results in Jun'24
  • INTEREST(HY) At HKD 0.76 MM has Grown at 186.04%
  • ROCE(HY) Lowest at 26.27%
  • DEBT-EQUITY RATIO (HY) Highest at -16.33 %
5
With ROE of 25.42%, it has a Very Attractive valuation with a 2.90 Price to Book Value
  • Over the past year, while the stock has generated a return of 42.86%, its profits have risen by 16.8% ; the PEG ratio of the company is 0.5
  • At the current price, the company has a high dividend yield of 186.9
6
Market Beating Performance
  • The stock has generated a return of 42.86% in the last 1 year, much higher than market (Hang Seng Hong Kong) returns of 8.25%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Uni-Bio Science Group Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Uni-Bio Science Group Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Uni-Bio Science Group Ltd.
42.86%
0.79
68.24%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
26.84%
EBIT Growth (5y)
31.59%
EBIT to Interest (avg)
25.14
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
1.63
Tax Ratio
6.39%
Dividend Payout Ratio
20.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.26%
ROE (avg)
14.78%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
2.90
EV to EBIT
9.39
EV to EBITDA
7.65
EV to Capital Employed
3.36
EV to Sales
1.59
PEG Ratio
0.47
Dividend Yield
186.87%
ROCE (Latest)
35.84%
ROE (Latest)
25.42%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
OPERATING CASH FLOW(Y)

Highest at HKD 196.21 MM

RAW MATERIAL COST(Y)

Fallen by -2.82% (YoY

CASH AND EQV(HY)

Highest at HKD 170.51 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.72 times

NET SALES(Q)

Highest at HKD 310.23 MM

OPERATING PROFIT(Q)

Highest at HKD 91.29 MM

OPERATING PROFIT MARGIN(Q)

Highest at 29.43 %

PRE-TAX PROFIT(Q)

Highest at HKD 78.65 MM

NET PROFIT(Q)

Highest at HKD 75.95 MM

EPS(Q)

Highest at HKD 0.01

-10What is not working for the Company
INTEREST(HY)

At HKD 0.76 MM has Grown at 186.04%

ROCE(HY)

Lowest at 26.27%

DEBT-EQUITY RATIO (HY)

Highest at -16.33 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.82 times

Here's what is working for Uni-Bio Science Group Ltd.

Operating Cash Flow
Highest at HKD 196.21 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Net Sales
Highest at HKD 310.23 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit
Highest at HKD 91.29 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin
Highest at 29.43 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at HKD 78.65 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
Highest at HKD 75.95 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD 0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Cash and Eqv
Highest at HKD 170.51 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 3.72 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -2.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 12.71 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 12.71 MM has Grown at 21.96%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Uni-Bio Science Group Ltd.

Interest
At HKD 0.76 MM has Grown at 186.04%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Debt-Equity Ratio
Highest at -16.33 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 4.82 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."